Literature DB >> 24180144

Sleep disturbances in patients with rheumatoid arthritis.

M Abbasi1, Z Yazdi, N Rezaie.   

Abstract

BACKGROUND: Sleep problems are frequent in chronic diseases like rheumatoid arthritis (RA). The present study was conducted to determine frequency of sleep disturbances and their relations with disease severity.
METHODS: The present case-control study was performed on 100 rheumatoid patients who were referred to the rheumatology clinic at the Avicenna hospital. A hundred age- and sex-matched healthy individuals were recruited in the study as a control group. Pittsburgh Sleep, 1Quality questionnaire, Insomnia Severity Index questionnaire and Epworth Sleepiness Scale were used. The disease activity was caIculated with the disease activity score 28. The collected data were analyzed using SPSS version 19.
RESULTS: Mean scores of the sleep quality were 6.2 +/- 4.3 in patients and 4.6 +/- 2.5 in control group. 28% of the patients had good sleep quality whereas 72% had poor sleep quality. Daytime sleepiness was present in 24.8% of the patients and 15% of the control group. Multiple logistic regressions showed that insomnia, pain and disease intensity were the most important factors that determine patients' sleep quality.
CONCLUSION: The present study showed that sleep disturbances are frequent in patients with RA and may contribute to disease severity. It is recommended that rheumatoid patients be evaluated for sleep disturbances during routine examinations.

Entities:  

Mesh:

Year:  2013        PMID: 24180144

Source DB:  PubMed          Journal:  Niger J Med        ISSN: 1115-2613


  9 in total

1.  Sleep quality and correlates of poor sleep in patients with rheumatoid arthritis.

Authors:  K Løppenthin; B A Esbensen; P Jennum; M Østergaard; A Tolver; T Thomsen; J Midtgaard
Journal:  Clin Rheumatol       Date:  2015-01-27       Impact factor: 2.980

2.  Relationship between Sleep Disorders, Pain and Quality of Life in Patients with Rheumatoid Arthritis.

Authors:  Majid Purabdollah; Sima Lakdizaji; Azad Rahmani; Mehrzad Hajalilu; Khalil Ansarin
Journal:  J Caring Sci       Date:  2015-09-01

Review 3.  Sleep impairment: an obstacle to achieve optimal quality of life in rheumatoid arthritis.

Authors:  Ilke Coskun Benlidayi
Journal:  Rheumatol Int       Date:  2018-09-11       Impact factor: 2.631

4.  Cognitive behavioural therapy for insomnia in patients with rheumatoid arthritis: protocol for the randomised, single-blinded, parallel-group Sleep-RA trial.

Authors:  K M Latocha; K B Løppenthin; M Østergaard; P J Jennum; R Christensen; M Hetland; H Røgind; T Lundbak; J Midtgaard; B A Esbensen
Journal:  Trials       Date:  2020-05-29       Impact factor: 2.279

Review 5.  Types of pain and their psychosocial impact in women with rheumatoid arthritis.

Authors:  Maria Gabriela Chancay; Shirin Nouri Guendsechadze; Irene Blanco
Journal:  Womens Midlife Health       Date:  2019-08-09

6.  The prevalence of insomnia and restless legs syndrome among Japanese outpatients with rheumatic disease: A cross-sectional study.

Authors:  Kayoko Urashima; Kunihiro Ichinose; Hideaki Kondo; Takahiro Maeda; Atsushi Kawakami; Hiroki Ozawa
Journal:  PLoS One       Date:  2020-03-20       Impact factor: 3.240

Review 7.  Sleep Problems in Chronic Inflammatory Diseases: Prevalence, Treatment, and New Perspectives: A Narrative Review.

Authors:  Marta Ditmer; Agata Gabryelska; Szymon Turkiewicz; Piotr Białasiewicz; Ewa Małecka-Wojciesko; Marcin Sochal
Journal:  J Clin Med       Date:  2021-12-23       Impact factor: 4.241

8.  Association of lifestyle and disease characteristics with self-rated wellness/health score in patients with rheumatoid arthritis.

Authors:  Reihane Tabaraii; Maryam Masoumi; Mahsa Bagherzadeh-Fard; Mohammad Amin Yazdanifar; Javad Balasi; Abbas Smiley
Journal:  BMC Rheumatol       Date:  2021-12-22

9.  The impact of gout on patient's lives: a study of African-American and Caucasian men and women with gout.

Authors:  Jasvinder A Singh
Journal:  Arthritis Res Ther       Date:  2014-06-24       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.